GO:0005048 signal sequence receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0005048 signal sequence receptor activity is a molecular function defined as binding to a signal sequence, a short stretch of amino acids that directs a protein to its proper cellular location.
• The signal sequence receptor (SSR) complex, also known as TRAP, is a membrane protein complex that interacts with signal sequences and is not essential for protein translocation, unlike the SRP receptor.
• SSR subunits such as SSR1 and SSR2 are implicated in human diseases including hepatocellular carcinoma and melanoma, where they influence ER stress responses and drug resistance.
• The SSR alpha subunit is phosphorylated by casein kinase II and associates with the membrane chaperone calnexin, linking signal sequence recognition to protein quality control.
• Signal sequence receptor activity can be studied using CRISPR knockout, point mutation, knock-in, and overexpression models, combined with proteomics, imaging, and functional assays.
• EDITGENE provides comprehensive CRISPR services to interrogate signal sequence receptor activity-related genes, from library screening to bioinformatics analysis.
Description
Signal sequence receptor activity (GO:0005048) is a molecular function that enables a protein to bind a signal sequence, a short amino-terminal or internal stretch of amino acids that acts as a postal code for protein localization within the cell. This activity is critical for the proper targeting of secretory and membrane proteins to the endoplasmic reticulum (ER) and other organelles, and it is mediated by the signal sequence receptor (SSR) complex, also known as the translocon-associated protein (TRAP) complex. The SSR complex is distinct from the signal recognition particle (SRP) receptor, and early studies demonstrated that the SSR is not essential for protein translocation, suggesting a modulatory or quality-control role. Researchers study GO:0005048 to understand how cells manage protein biogenesis, ER homeostasis, and how defects in these processes contribute to diseases such as cancer and ER stress-related disorders.
signal sequence receptor activity At A Glance
| GO ID | GO:0005048 |
|---|---|
| GO term | signal sequence receptor activity |
| Ontology | molecular_function |
| Synonym | leader sequence binding, protein signal sequence binding, signal sequence binding, signal sequence receptor |
| Major function | Binding to a signal sequence to direct proper protein localization |
| Definition | Binding to a signal sequence, a short stretch of amino acids found in a protein that acts as a signal for its proper localization in the cell. |
| Related complex | Signal sequence receptor (SSR) complex, also known as TRAP complex |
| Associated genes | SSR1, SSR2, SSR3, SSR4 |
| Disease relevance | Cancer (hepatocellular carcinoma, melanoma), ER stress-related disorders |
What Is GO:0005048?
According to the Gene Ontology, GO:0005048 signal sequence receptor activity is defined as binding to a signal sequence, a short stretch of amino acids found in a protein that acts as a signal for its proper localization in the cell. In other words, it is the function of a receptor protein that recognizes and binds to these targeting signals, facilitating the correct transport of proteins to their destinations, such as the endoplasmic reticulum, mitochondria, or chloroplasts.
Why Is signal sequence receptor activity Important in Cell Biology?
Signal sequence receptor activity is fundamental to cellular protein homeostasis because it ensures that newly synthesized proteins are correctly targeted to their appropriate subcellular compartments. Dysregulation of this activity can lead to protein mislocalization, ER stress, and activation of the unfolded protein response (UPR), which contributes to cancer progression, drug resistance, and other pathologies. Understanding GO:0005048 provides insights into basic cell biology and offers potential therapeutic targets, as evidenced by studies linking SSR subunits to hepatocellular carcinoma prognosis and melanoma survival.
• Essential for proper protein targeting and localization in eukaryotic cells.
• Involved in the unfolded protein response and ER stress management.
• SSR1 expression is associated with diagnosis and prognosis of hepatocellular carcinoma.
• SSR2 promotes sorafenib resistance in liver cancer by interacting with GPX4 to inhibit ferroptosis.
• SSR2 is required for survival of human melanoma cells under ER stress.
• Phosphorylation of SSR alpha by casein kinase II links signal sequence recognition to chaperone function.
• Signal sequence receptor activity can be studied using CRISPR-based gene editing to create knockout, point mutation, and knock-in models.
• Potential target for cancer therapy, especially in cancers with high ER stress.
• Provides a model for understanding signal sequence-independent targeting pathways.
• Relevant to chloroplast protein import in plants, highlighting evolutionary conservation.
Molecular Mechanism of signal sequence receptor activity
Signal Sequence Recognition and Binding
In simple terms: The receptor grabs onto a short tag on a new protein to know where it should go.
The signal sequence receptor (SSR) complex binds to signal sequences, which are short stretches of amino acids typically found at the N-terminus of nascent polypeptides. This binding is the first step in directing proteins to the endoplasmic reticulum (ER) membrane. The SSR complex, also known as TRAP, interacts with the signal sequence as it emerges from the ribosome, facilitating its engagement with the translocon. Unlike the SRP receptor, the SSR is not essential for translocation but may modulate efficiency or proofreading.
Interaction with the Translocon and Chaperones
In simple terms: The receptor works with other proteins to help the new protein enter the ER and fold correctly.
The SSR complex associates with the Sec61 translocon and membrane chaperones such as calnexin. The alpha subunit of SSR is phosphorylated by casein kinase II, which may regulate its interaction with calnexin and other components. This phosphorylation event links signal sequence recognition to protein folding and quality control in the ER. The SSR complex is thought to stabilize the translocon and assist in the co-translational translocation of proteins.
Signal Sequence-Independent Pathways
In simple terms: Sometimes proteins can be targeted without the usual signal sequence, using alternative routes.
Studies have shown that SRP-SR complex formation can occur at the membrane in a signal sequence-independent manner, suggesting an alternative targeting pathway within the SRP cycle. This implies that signal sequence receptor activity may not be the sole mechanism for protein targeting, and other factors can compensate or provide alternative routes. The existence of such pathways highlights the complexity and redundancy of protein targeting systems.
Role in ER Stress and Unfolded Protein Response
In simple terms: When the ER is stressed, the receptor helps cells survive by managing protein load.
The SSR complex, particularly SSR2, is required for survival of human melanoma cells as part of an unfolded protein response to ER stress. Knockdown of SSR2 leads to increased ER stress and apoptosis, indicating its protective role. In hepatocellular carcinoma, SSR1 expression is associated with clinical outcomes and may influence ER homeostasis. Thus, signal sequence receptor activity is integrated into cellular stress responses.
Phosphorylation and Regulation
In simple terms: The receptor can be chemically modified, which changes how it works.
The alpha subunit of the signal sequence receptor is phosphorylated by casein kinase II, and this modification affects its association with calnexin. This phosphorylation may regulate the receptor's function in protein translocation and folding. Additionally, the SSR complex is subject to regulation by ER stress pathways, as its expression levels change under conditions that induce the unfolded protein response.
Key Genes Involved in GO:0005048 signal sequence receptor activity
The following genes encode proteins that constitute or interact with the signal sequence receptor complex and are directly relevant to GO:0005048.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SSR1 | Signal sequence receptor subunit alpha; binds signal sequences and interacts with calnexin | Associated with hepatocellular carcinoma diagnosis and prognosis; phosphorylated by casein kinase II |
| SSR2 | Signal sequence receptor subunit beta; part of TRAP complex | Promotes sorafenib resistance via GPX4 inhibition of ferroptosis; required for melanoma survival under ER stress |
| SSR3 | Signal sequence receptor subunit gamma; component of TRAP complex | Part of the SSR complex involved in protein translocation |
| SSR4 | Signal sequence receptor subunit delta; component of TRAP complex | Part of the SSR complex involved in protein translocation |
| SEC61A1 | Main subunit of the Sec61 translocon | Interacts with SSR complex during protein translocation |
| CANX | Calnexin, a membrane chaperone | Associates with SSR alpha and is involved in protein folding |
| CSNK2A1 | Casein kinase II subunit alpha | Phosphorylates SSR alpha |
| GPX4 | Glutathione peroxidase 4 | Interacts with SSR2 to inhibit ferroptosis |
| SRPRA | Signal recognition particle receptor subunit alpha | Functions in SRP-dependent targeting, distinct from SSR |
| SRPRB | Signal recognition particle receptor subunit beta | Functions in SRP-dependent targeting |
| HSPA5 | BiP, ER chaperone | Part of ER stress response that may regulate SSR expression |
| DDIT3 | CHOP, ER stress-induced transcription factor | Mediates UPR and may affect SSR2-dependent survival |
| XBP1 | X-box binding protein 1 | UPR transcription factor that may regulate SSR genes |
| ATF4 | Activating transcription factor 4 | UPR transcription factor involved in ER stress response |
| ATF6 | Activating transcription factor 6 | UPR sensor that may influence SSR expression |
| ERN1 | IRE1, ER stress sensor | Initiates UPR and may regulate SSR genes |
| EIF2AK3 | PERK, ER stress kinase | Phosphorylates eIF2α to attenuate translation under ER stress |
How Is signal sequence receptor activity Regulated?
Signal sequence receptor activity is regulated at multiple levels. The SSR alpha subunit is phosphorylated by casein kinase II, which modulates its interaction with calnexin and potentially its function in protein translocation. Under ER stress, the unfolded protein response (UPR) is activated, leading to changes in the expression of SSR subunits; for example, SSR2 is required for melanoma cell survival during ER stress, and its knockdown exacerbates stress. Additionally, the SSR complex may be regulated by the availability of signal sequences and the presence of alternative targeting pathways. In hepatocellular carcinoma, SSR1 expression is associated with clinical features, suggesting that its regulation is relevant to disease.
signal sequence receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SSR1 | Hepatocellular carcinoma diagnosis and prognosis | Knockout or overexpression in liver cancer cell lines (e.g., HepG2) |
| SSR2 | Sorafenib resistance in liver cancer; melanoma survival under ER stress | Knockout in melanoma cell lines (e.g., A375) and liver cancer cells |
| SSR2 | Ferroptosis inhibition via GPX4 interaction | Point mutation to disrupt SSR2-GPX4 interaction |
| SSR1 | ER stress response and calnexin interaction | Phosphorylation-site mutants (point mutation) |
| SSR3/SSR4 | Protein translocation efficiency | Knockout in HEK293 cells followed by proteomics |
Signal Sequence Receptor Activity in Cancer
Dysregulation of signal sequence receptor activity is increasingly linked to cancer. In hepatocellular carcinoma, high expression of SSR1 is associated with poor prognosis and may serve as a diagnostic marker. SSR2 promotes sorafenib resistance in liver cancer by interacting with GPX4 to inhibit ferroptosis, a form of cell death. In melanoma, SSR2 is required for cell survival under ER stress, and its depletion leads to increased apoptosis. These findings suggest that targeting signal sequence receptor activity could be a therapeutic strategy in cancers with high ER stress or drug resistance.
ER Stress and Unfolded Protein Response
The signal sequence receptor complex is intimately involved in the unfolded protein response (UPR). SSR2 is required for survival of human melanoma cells as part of an UPR to ER stress. Knockdown of SSR2 leads to increased ER stress markers and cell death, indicating that it plays a protective role. This connection highlights how signal sequence receptor activity contributes to cellular adaptation to stress, and its dysfunction may exacerbate diseases characterized by ER stress, such as neurodegeneration and diabetes.
Potential in Other Diseases
While direct links to neurodegeneration or ribosomopathies are not yet established for GO:0005048, the fundamental role of signal sequence receptor activity in protein targeting suggests that defects could contribute to a range of diseases. For example, impaired protein localization is a hallmark of many neurodegenerative disorders. However, specific evidence from the provided citations is limited to cancer and ER stress. Further research is needed to explore other disease contexts.
From signal sequence receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is SSR1 required for hepatocellular carcinoma growth? | CRISPR knockout of SSR1 in HepG2 cells |
| Does SSR2 phosphorylation affect its interaction with GPX4? | Point mutation of phosphorylation sites in SSR2 |
| Can we tag endogenous SSR1 to study its localization? | Knock-in of fluorescent tag (e.g., GFP) at SSR1 locus |
| Does overexpression of SSR2 confer sorafenib resistance? | Overexpression of SSR2 in liver cancer cells |
| What is the role of SSR2 in ER stress survival? | CRISPR knockout of SSR2 in melanoma cells followed by ER stress induction |
| Does SSR alpha phosphorylation regulate calnexin binding? | Point mutation of casein kinase II sites in SSR1 |
How to Study the signal sequence receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation (Co-IP) | Protein-protein interactions | Identify SSR binding partners like calnexin |
| Mass spectrometry | Protein identification and phosphorylation sites | Map SSR post-translational modifications |
| Fluorescence microscopy | Subcellular localization and dynamics | Visualize GFP-tagged SSR subunits |
| In vitro translocation assay | Protein import into ER | Test requirement for SSR in translocation |
| CRISPR knockout | Gene function | Assess loss-of-function phenotypes |
| RNA-seq | Transcriptional changes | Measure ER stress response genes upon SSR perturbation |
| Phosphoproteomics | Phosphorylation status | Identify casein kinase II sites on SSR1 |
| Bioinformatics analysis | Clinical correlations | Link SSR1 expression to hepatocellular carcinoma prognosis |
Proteomics and Interactomics
To study signal sequence receptor activity, researchers can use affinity purification coupled with mass spectrometry to identify proteins that interact with the SSR complex, such as calnexin and GPX4. Phosphoproteomics can reveal phosphorylation sites on SSR subunits, such as those modified by casein kinase II. These methods help elucidate the molecular mechanisms and regulation of GO:0005048.
Imaging and Localization
Fluorescence microscopy of tagged SSR subunits (e.g., GFP knock-in) can visualize their subcellular localization and dynamics during protein translocation. Co-localization with ER markers and the translocon can confirm their site of action. Live-cell imaging can track the real-time interaction of signal sequences with the SSR complex.
Functional Assays for Protein Translocation
In vitro translocation assays using microsomes and radiolabeled proteins can measure the efficiency of protein import into the ER in the presence or absence of SSR subunits. Knockdown or knockout of SSR genes followed by these assays can determine their requirement for translocation. Additionally, cell-based assays measuring ER stress markers (e.g., CHOP, BiP) can assess the role of SSR in the UPR.
CRISPR Screening and Bioinformatics
Genome-wide CRISPR knockout screens can identify genes that modulate signal sequence receptor activity or compensate for its loss. Bioinformatics analysis of transcriptomic data from cancer patients can reveal correlations between SSR expression and clinical outcomes, as done for SSR1 in hepatocellular carcinoma. These approaches can uncover novel regulators and disease associations.
How CRISPR Can Be Used to Study GO:0005048 signal sequence receptor activity
Knockout
CRISPR knockout of SSR genes (e.g., SSR1, SSR2) can be used to study their essentiality and function in protein translocation and ER stress. For example, knockout of SSR2 in melanoma cells increases sensitivity to ER stress-induced apoptosis. Knockout of SSR1 in liver cancer cells can reveal its role in tumor growth and drug resistance. These models are valuable for validating the role of signal sequence receptor activity in disease.
Point Mutation
Point mutations can be introduced into SSR genes to study specific residues, such as phosphorylation sites or signal sequence binding domains. For instance, mutating the casein kinase II phosphorylation sites on SSR1 can determine their role in calnexin interaction. Point mutations in SSR2 that disrupt GPX4 binding can elucidate the mechanism of ferroptosis inhibition. These models provide precise mechanistic insights.
Knock-in
Knock-in of tags (e.g., GFP, HA) at endogenous SSR loci allows for real-time imaging and biochemical purification of the SSR complex. This approach preserves native regulation and can reveal dynamic interactions with the translocon and chaperones. Knock-in of disease-associated mutations can also model human pathologies.
Overexpression
Overexpression of SSR subunits can be used to study gain-of-function effects, such as increased protein translocation efficiency or drug resistance. For example, overexpression of SSR2 in liver cancer cells confers resistance to sorafenib by inhibiting ferroptosis. Overexpression models are useful for identifying downstream pathways and potential therapeutic targets.
How EDITGENE Supports signal sequence receptor activity Research
Researchers studying signal sequence receptor activity-related genes often need to determine whether a candidate gene is causally involved in protein targeting, ER stress, or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of these genes.
Contact EDITGENE today to design your custom CRISPR model for signal sequence receptor activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| AP2B1 Knockout HEK293 Cell Line | EDJ-KQ4018 | Human | 163 | Details Get a Quote |
| AP2M1 Knockout HEK293 Cell Line | EDJ-KQ4286 | Human | 1173 | Details Get a Quote |
| SEC61A2 Knockout HEK293 Cell Line | EDJ-KQ15214 | Human | 55176 | Details Get a Quote |
| AP2B1 Knockout HeLa Cell Line | EDJ-KQ25014 | Human | 163 | Details Get a Quote |
| SEC61A2 Knockout A-549 Cell Line | EDJ-KQ45865 | Human | 55176 | Details Get a Quote |
| SEC61A2 Knockout HCT 116 Cell Line | EDJ-KQ45866 | Human | 55176 | Details Get a Quote |
| SEC61A2 Knockout HeLa Cell Line | EDJ-KQ45867 | Human | 55176 | Details Get a Quote |
| AP2M1 Knockout A-549 Cell Line | EDJ-KQ25468 | Human | 1173 | Details Get a Quote |
| AP2B1 Knockout A-549 Cell Line | EDJ-KQ26353 | Human | 163 | Details Get a Quote |
| AP2B1 Knockout HCT 116 Cell Line | EDJ-KQ26354 | Human | 163 | Details Get a Quote |
| AP2M1 Knockout HCT 116 Cell Line | EDJ-KQ26769 | Human | 1173 | Details Get a Quote |
| AP2M1 Knockout HeLa Cell Line | EDJ-KQ26770 | Human | 1173 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About signal sequence receptor activity
What is signal sequence receptor activity?
Signal sequence receptor activity (GO:0005048) is a molecular function defined as binding to a signal sequence, a short stretch of amino acids that directs a protein to its proper location in the cell.
What genes are involved in signal sequence receptor activity?
Key genes include SSR1, SSR2, SSR3, and SSR4, which encode subunits of the signal sequence receptor complex.
What is the function of the signal sequence receptor?
The signal sequence receptor binds to signal sequences on nascent proteins to facilitate their targeting to the endoplasmic reticulum and proper localization.
Is the signal sequence receptor essential for protein translocation?
No, studies have shown that the signal sequence receptor is not essential for protein translocation, unlike the SRP receptor.
How is signal sequence receptor activity regulated?
It is regulated by phosphorylation (e.g., by casein kinase II) and by ER stress pathways that induce the unfolded protein response.
What diseases are associated with signal sequence receptor activity?
Dysregulation has been linked to hepatocellular carcinoma, melanoma, and drug resistance, particularly through SSR1 and SSR2.
How can I study signal sequence receptor activity using CRISPR?
You can use CRISPR knockout, point mutation, knock-in, or overexpression models to interrogate gene function, followed by functional assays.
What methods are used to measure signal sequence receptor activity?
Common methods include co-immunoprecipitation, mass spectrometry, fluorescence microscopy, and in vitro translocation assays.
Does SSR2 play a role in ferroptosis?
Yes, SSR2 interacts with GPX4 to inhibit ferroptosis, contributing to sorafenib resistance in liver cancer.
What is the relationship between SSR1 and cancer?
SSR1 expression is associated with diagnosis and prognosis of hepatocellular carcinoma and may influence ER homeostasis.
Conclusion
Signal sequence receptor activity (GO:0005048) is a fundamental molecular function that ensures proper protein targeting and cellular homeostasis. Its dysregulation is implicated in cancer and ER stress-related diseases, making it a compelling target for research and therapeutic development. By leveraging CRISPR-based models and advanced analytical methods, researchers can uncover the precise mechanisms and disease relevance of this activity, paving the way for novel interventions.
References
- 1. Song Z et al.. 2026. SSR2 Promotes Sorafenib Resistance Via Interacting with GPX4 to Inhibit Ferroptosis.. Curr Mol Med PMID: 41568502
- 2. Migliaccio G et al.. 1992. The signal sequence receptor, unlike the signal recognition particle receptor, is not essential for protein translocation.. J Cell Biol 117(1):15-25 PMID: 1313437
- 3. Chen L et al.. 2021. Clinical Value for Diagnosis and Prognosis of Signal Sequence Receptor 1 (SSR1) and Its Potential Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on High-Throughput Data Analysis.. Int J Gen Med 14:7435-7451 PMID: 34744454
- 4. Garg B et al.. 2016. Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.. Mutagenesis 31(5):573-82 PMID: 27180333
- 5. Ou WJ et al.. 1992. Casein kinase II phosphorylation of signal sequence receptor alpha and the associated membrane chaperone calnexin.. J Biol Chem 267(33):23789-96 PMID: 1331100
- 6. Braig D et al.. 2011. Signal sequence-independent SRP-SR complex formation at the membrane suggests an alternative targeting pathway within the SRP cycle.. Mol Biol Cell 22(13):2309-23 PMID: 21551068
- 7. Robinson A et al.. 1987. The role of topogenic sequences in the movement of proteins through membranes.. Biochem J 246(2):249-61 PMID: 3318806
- 8. Soll J. 2002. Protein import into chloroplasts.. Curr Opin Plant Biol 5(6):529-35 PMID: 12393016
